Researchers report effective single-dose vaccine targeting influenza, COVID-19, and RSV
Researchers have developed an experimental single-dose vaccine that shows promising protection against three respiratory diseases: seasonal influenza, COVID-19, and respiratory syncytial virus (RSV). The study demonstrated that the vaccine, which is based on spherical particles coated with a phospholipid membrane, elicits a strong immune response in both mice and rats without losing effectiveness when combined with three different components. This approach differs from traditional COVID-19 vaccines that rely on mRNA technology, and further studies are needed to understand how interactions between the vaccine components influence the immune response.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)